Xing Lü

Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent

Xing Lü, Yan‐Cheng Liu, Chris Orvig et al. · Journal of Medicinal Chemistry · 2020 · 42 citations · Full text

Humoral immune response limits gene therapy in canine MPS I [letter]

Robert M. Shull, Xing Lü, Ian D. Dubé et al. · Blood · 1996 · 41 citations · Full text

Immunogenetics, Gene Therapies, Autoimmune Disease +10

Rhodium(<scp>iii</scp>) complexes with isoquinoline derivatives as potential anticancer agents: <i>in vitro</i> and <i>in vivo</i> activity studies

Taj-Malook Khan, Noor Shad Gul, Xing Lü et al. · Dalton Transactions · 2019 · 41 citations

Transcriptional signature of flavopiridol-induced tumor cell death

Xing Lü, William Burgan, Michael Cerra et al. · Molecular Cancer Therapeutics · 2004 · 38 citations

In vitro and in vivo anti-tumor activity of two gold(III) complexes with isoquinoline derivatives as ligands

Taj-Malook Khan, Noor Shad Gul, Xing Lü et al. · European Journal of Medicinal Chemistry · 2018 · 38 citations

Inorganic Chemistry, Biochemistry, Coordination Complex +5